Background. The high prevalence of depressive and anxiety disorders in people with COVID-19 and the lack of data on depression and / or anxiety in higher education students who relapsed to COVID-19 led to the study. The purpose of the study was to assess the prevalence of anxiety and depression, as well as to identify risk factors for the development of these conditions in medical students of the DSMU.
Methods. A one-off cross-sectional epidemiological study involving 154 respondents who voluntarily and anonymously completed a questionnaire with complaints, anamnestic data, and a self-assessment scale for depression PHQ-9 (cut-off point 10) and anxiety GAD-7 (cut-off point 10 points).
Results. The prevalence of depression among medical students who relapsed to COVID-19 is 44.8%, which is higher than in the population of people who relapsed to COVID-19, the prevalence of anxiety is 27.9%, which is within the prevalence of other people who relapsed to COVID-19. COVID-19.
The main independent factors in the development of depression were identified: anxiety (OR: 22,069; 95% [CI]: 7,941-61,335; p <0,05), hospitalization (OR: 5,443; 95% [CI]: 1,116-26,540; p < 0.05), CT / MRI (OR: 6,345; 95% [CI]: 1,728-23,296; p <0,05), glucocorticoids during illness (OR: 8,936; 95% [CI]: 2,495-31,999 p <0.05).
The main factors of anxiety: fatigue (OR: 5,563; 95% [CI]: 1,605-19,286; p <0,05), weakness (OR: 9,477; 95% [CI]: 2,764-32,495; p <0,05) , hospitalization (OR: 11,568; 95% [CI]: 2,350-56,950; p <0,05), depression (OR: 22,069; 95% [CI]: 7,941-61,335; p <0,05).
The level of blood saturation did not affect the development of depression and / or anxiety.
Conclusions. Higher medical school students, unlike other COVID-19 survivors, have higher rates of depression. The identified risk factors for anxiety or depression indicate a large role for comorbid depression and anxiety, as well as the severity of COVID-19. Risk factors for anxiety and depressive disorders are probably not related to organic damage to the central nervous system, but to the psychological response to a potentially fatal disease.
Full-text of the article is available for this locale: Українська.
- Rogers JP, Chesney E, Oliver D, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7(7):611-627. doi:10.1016/S2215-0366(20)30203-0
- Mina FB, Billah M, Karmakar S, et al. An online observational study assessing clinical characteristics and impacts of the COVID-19 pandemic on mental health: a perspective study from Bangladesh. J Public Health (Berl). Published online January 7, 2021. doi:10.1007/s10389-020-01445-2
- Lai J, Ma S, Wang Y, et al. Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019. JAMA Netw Open. 2020;3(3):e203976. doi:10.1001/jamanetworkopen.2020.3976
- Mei Q, Wang F, Bryant A, Wei L, Yuan X, Li J. Mental health problems among COVID-19 survivors in Wuhan, China. World Psychiatry. 2021;20(1):139-140. doi:10.1002/wps.20829
- Maruta NO, Markova MV, Kozhyna HM, et al. Psychological factors and consequences of psychosocial stress during the pandemic. Wiadomości Lekarskie. 2021;74(9 p.I):2175-2181. doi:10.36740/WLek202109126
- Chaban OS, Khaustova OO, Mishyiev VD, Grinevich EG, Assonov DO. Resilience Influence to Healthcare Professionals’ Emotional State During COVID-19 Quarantine. Psychiatry psychotherapy and clinical psychology. 2021;12(1):150-157. doi:10.34883/PI.2021.12.1.013
- Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613. doi:10.1046/j.1525-1497.2001.016009606.x
- Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092-1097. doi:10.1001/archinte.166.10.1092
- Wang X, Tao J, Zhu Q, et al. Depression and anxiety symptoms to COVID-19 outbreak among the public, medical staff and patients during the initial phase of the pandemic: an online questionnaire survey by a WeChat Mini Program. BMJ Open. 2021;11(6):e046350. doi:10.1136/bmjopen-2020-046350
- Marzo RR, Ismail Z, Nu Htay MN, et al. Psychological distress during pandemic Covid-19 among adult general population: Result across 13 countries. Clin Epidemiol Glob Health. 2021;10:100708. doi:10.1016/j.cegh.2021.100708
- Wathelet M, Duhem S, Vaiva G, et al. Factors Associated With Mental Health Disorders Among University Students in France Confined During the COVID-19 Pandemic. JAMA Netw Open. 2020;3(10):e2025591. doi:10.1001/jamanetworkopen.2020.25591
- Son C, Hegde S, Smith A, Wang X, Sasangohar F. Effects of COVID-19 on College Students’ Mental Health in the United States: Interview Survey Study. J Med Internet Res. 2020;22(9):e21279. doi:10.2196/21279
- Du J, Mayer G, Hummel S, et al. Mental Health Burden in Different Professions During the Final Stage of the COVID-19 Lockdown in China: Cross-sectional Survey Study. J Med Internet Res. 2020;22(12):e24240. doi:10.2196/24240
- Zhou S-J, Zhang L-G, Wang L-L, et al. Prevalence and socio-demographic correlates of psychological health problems in Chinese adolescents during the outbreak of COVID-19. Eur Child Adolesc Psychiatry. Published online May 3, 2020:1-10. doi:10.1007/s00787-020-01541-4
- Ma Z, Zhao J, Li Y, et al. Mental health problems and correlates among 746 217 college students during the coronavirus disease 2019 outbreak in China. Epidemiol Psychiatr Sci. 2020;29:e181. doi:10.1017/S2045796020000931
- Zhao Y, Guo J, Liu S, et al. Prevalence and Related Factors of Depression, Anxiety, Acute Stress, and Insomnia Symptoms Among Medical Staffs Experiencing the Second Wave of COVID-19 Pandemic in Xinjiang, China. Front Public Health. 2021;9:671400. doi:10.3389/fpubh.2021.671400